Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Parvin Begum"'
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 9, Pp 100376- (2022)
ROS1: gene rearrangements occur in 1% to 2% of NSCLC. Acquired “on-target” mutations within the ROS1 kinase domain are a known resistance mechanism to the first-line ROS1 inhibitor crizotinib. Here, we report the first case of a patient with an a
Externí odkaz:
https://doaj.org/article/cf7508faad194a2bacfe5deaac19967c
Autor:
Parvin Begum, MBChB.(Hons), Robert D. Goldin, MD, Lucia A. Possamai, PhD, Sanjay Popat, FRCP, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 9, Pp 100213- (2021)
Sotorasib is a first-in-class small molecule that irreversibly inhibits KRAS G12C, locking it in an inactive state, inhibiting oncogenic signaling, and inducing a proinflammatory microenvironment. Here, we report the first case of life-threatening he
Externí odkaz:
https://doaj.org/article/d35246bc42e64d37a88a15bf7ca7fe13
Publikováno v:
Nanomaterials, Vol 4, Iss 2, Pp 203-221 (2014)
Phytotoxicity is a significant consideration in understanding the potential environmental impact of nanoparticles. Abundant experimental data have shown that multi-walled carbon nanotubes (MWNTs) are toxic to plants, but the potential impacts of expo
Externí odkaz:
https://doaj.org/article/a96f86abef714ea7bc9ce9ad4ab53966
Autor:
Nicolò Matteo Luca Battisti, Laura Morrison, Tamsin Nash, Nishanti Senthivel, Samantha Kestenbaum, Parvin Begum, Mariam Obeid, William Hayhurst, Dorothy Yang, Shafiah Gafoor, Caroline Brown, Farah Rehman, Laura Kenny, Olivia Hatcher, Susan Susan, Jennet Williams, Anna Brown, Hamoun Rozati, Alexandros Alexandros, Elinor Sawyer, Charalampos Gousis, Eleni Karapanagiotou, Anna Rigg, Kleopatra Rapti, Rebecca Roylance, Mark Beresford, Abigail L Gee, Apostolos Konstantis, Judy King, Mark Nathan, Emma Spurrell, Mark Pearce, Dane Bradwell, Arshi Denton, Kate Swain, Sophie McGrath, Mark Allen, Alistair Ring, Stephen Johnston, Fharat Raja
Publikováno v:
Cancer Research. 82:P1-17
Background Abemaciclib is approved in 1st and 2nd line for hormone receptor (HR)-positive HER2-negative advanced breast cancer (ABC). However, outcomes on this agent are unclear in the real world.We determined the safety and efficacy profile of abema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46078e8a48bea41baf70095f039369ae
https://doi.org/10.1158/1538-7445.sabcs21-p1-17-08
https://doi.org/10.1158/1538-7445.sabcs21-p1-17-08
Publikováno v:
ACS Food Science & Technology. 1:2030-2040
In this work, we developed a polyaniline (PANI)-modified electrochemical sensor chip via electrochemical polymerization that resists nonspecific adsorption for wine component (SO2, phenolic/organic...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b33555148e4f4b3e70b2103f8f3ce3b4
https://doi.org/10.1021/acsfoodscitech.1c00146
https://doi.org/10.1021/acsfoodscitech.1c00146
Publikováno v:
Food Chemistry. 414:135740
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a971c79931cab4266b52b39bfdbfdecf
https://doi.org/10.1016/j.foodchem.2023.135740
https://doi.org/10.1016/j.foodchem.2023.135740
Publikováno v:
The Handbook of Environmental Chemistry ISBN: 9789811952357
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2962c76f09934991dc667879c9e4177e
https://doi.org/10.1007/698_2022_844
https://doi.org/10.1007/698_2022_844
Publikováno v:
International Journal of Scientific & Engineering Research. 10:557-566
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a71b968c611440eee6fa15a2b1bfa8da
https://doi.org/10.14299/ijser.2019.09.08
https://doi.org/10.14299/ijser.2019.09.08
Autor:
Parvin Begum, Mohammad Shafiqul Islam
Aim: As households’ health-seeking behavior depends enormously on socio-economic and demographic factors particularly in developing county like Bangladesh, it contributes differently to health-care seeking behavior varying household to household. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8eb91f5c223bc60a1290574f8982a57f
https://doi.org/10.21203/rs.3.rs-45708/v1
https://doi.org/10.21203/rs.3.rs-45708/v1
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 9, Pp 100213-(2021)
JTO Clinical and Research Reports
JTO Clinical and Research Reports
Sotorasib is a first-in-class small molecule that irreversibly inhibits KRAS G12C, locking it in an inactive state, inhibiting oncogenic signaling, and inducing a proinflammatory microenvironment. Here, we report the first case of life-threatening he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a65490f2704d499dbecb06c779bdd78
https://doi.org/10.1016/j.jtocrr.2021.100213
https://doi.org/10.1016/j.jtocrr.2021.100213